278 related articles for article (PubMed ID: 26351036)
21. Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.
Yu L; Wang Y; Xing D; Gong P; Chen Q; Lv Y
Medicine (Baltimore); 2020 Dec; 99(52):e23857. PubMed ID: 33350778
[TBL] [Abstract][Full Text] [Related]
22. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.
King V; Gu Y; Kaplan JB; Brooks JD; Pike MC; Morris EA
Eur Radiol; 2012 Dec; 22(12):2641-7. PubMed ID: 22752463
[TBL] [Abstract][Full Text] [Related]
23. Fully automatic quantification of fibroglandular tissue and background parenchymal enhancement with accurate implementation for axial and sagittal breast MRI protocols.
Wei D; Jahani N; Cohen E; Weinstein S; Hsieh MK; Pantalone L; Kontos D
Med Phys; 2021 Jan; 48(1):238-252. PubMed ID: 33150617
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
[TBL] [Abstract][Full Text] [Related]
25. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
[TBL] [Abstract][Full Text] [Related]
26. Hormonal Effects on Breast Density, Fibroglandular Tissue, and Background Parenchymal Enhancement.
Heller SL; Young Lin LL; Melsaether AN; Moy L; Gao Y
Radiographics; 2018; 38(4):983-996. PubMed ID: 29856684
[TBL] [Abstract][Full Text] [Related]
27. Relationship Between Breast Ultrasound Background Echotexture and Magnetic Resonance Imaging Background Parenchymal Enhancement and the Effect of Hormonal Status Thereon.
Kim SJ; Jung HK; Han BK; Lee JH; Oh KS; Lee JS; Lee Y
Ultrasound Q; 2020 Jun; 36(2):179-191. PubMed ID: 32511210
[TBL] [Abstract][Full Text] [Related]
28. Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.
Ko KH; Jung HK; Kim I
Medicine (Baltimore); 2017 Aug; 96(33):e7850. PubMed ID: 28816987
[TBL] [Abstract][Full Text] [Related]
29. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.
Vierkant RA; Degnim AC; Radisky DC; Visscher DW; Heinzen EP; Frank RD; Winham SJ; Frost MH; Scott CG; Jensen MR; Ghosh K; Manduca A; Brandt KR; Whaley DH; Hartmann LC; Vachon CM
BMC Cancer; 2017 Jan; 17(1):84. PubMed ID: 28143431
[TBL] [Abstract][Full Text] [Related]
30. Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.
Xu C; Jiang M; Lin F; Zhang K; Xie H; Lv W; Ji H; Mao N
Br J Radiol; 2023 Aug; 96(1148):20220051. PubMed ID: 37227804
[TBL] [Abstract][Full Text] [Related]
31. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.
Narayan AK; Visvanathan K; Harvey SC
Breast Cancer Res Treat; 2016 Aug; 158(3):583-9. PubMed ID: 27444927
[TBL] [Abstract][Full Text] [Related]
32. The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI.
Hellgren R; Saracco A; Strand F; Eriksson M; Sundbom A; Hall P; Dickman PW
Acta Radiol; 2020 Dec; 61(12):1600-1607. PubMed ID: 32216451
[TBL] [Abstract][Full Text] [Related]
33. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
[TBL] [Abstract][Full Text] [Related]
34. Background uptake of breast-specific gamma imaging: correlation with mammographic breast density and background enhancement of breast MRI.
Kim MY; Choi N; Ko SM; Chung HW
Clin Imaging; 2014; 38(3):255-8. PubMed ID: 24461560
[TBL] [Abstract][Full Text] [Related]
35. Quantitative breast density analysis using tomosynthesis and comparison with MRI and digital mammography.
Moon WK; Chang JF; Lo CM; Chang JM; Lee SH; Shin SU; Huang CS; Chang RF
Comput Methods Programs Biomed; 2018 Feb; 154():99-107. PubMed ID: 29249352
[TBL] [Abstract][Full Text] [Related]
36. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
37. Correlation of background parenchymal enhancement on breast MRI with breast cancer.
Sallam H; Lenga L; Solbach C; Becker S; Vogl TJ
Clin Radiol; 2023 Sep; 78(9):e654-e659. PubMed ID: 37330320
[TBL] [Abstract][Full Text] [Related]
38. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
[TBL] [Abstract][Full Text] [Related]
39. Correlation Between Mammographic Breast Density, Breast Tissue Type in Ultrasonography, Fibroglandular Tissue, and Background Parenchymal Enhancement in Magnetic Resonance Imaging.
Alikhassi A; Miratashi Yazdi SN; Akbari H; Kia SA; Baikpour M
Breast Cancer (Auckl); 2018; 12():1178223418771971. PubMed ID: 29706765
[TBL] [Abstract][Full Text] [Related]
40. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.
Wu AH; Spicer D; Garcia A; Tseng CC; Hovanessian-Larsen L; Sheth P; Martin SE; Hawes D; Russell C; MacDonald H; Tripathy D; Su MY; Ursin G; Pike MC
Cancer Prev Res (Phila); 2015 Oct; 8(10):942-51. PubMed ID: 26276750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
